Ananda Pharma Plc (AQU:ANA)
0.2250
0.00 (0.00%)
At close: Nov 11, 2025
Ananda Pharma Balance Sheet
Financials in millions GBP. Fiscal year is February - January.
Millions GBP. Fiscal year is Feb - Jan.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2019 - 2020 |
Cash & Equivalents | 1.66 | 0.08 | 0.02 | - | - | Upgrade |
Cash & Short-Term Investments | 1.66 | 0.08 | 0.02 | - | - | Upgrade |
Cash Growth | 1870.96% | 348.22% | - | - | - | Upgrade |
Accounts Receivable | 0 | - | - | - | - | Upgrade |
Other Receivables | 0.1 | 0.05 | 0.18 | 0.09 | 0 | Upgrade |
Receivables | 0.1 | 0.05 | 0.18 | 0.09 | 0 | Upgrade |
Prepaid Expenses | 0.05 | 0.03 | 0.03 | 0.02 | 0.01 | Upgrade |
Other Current Assets | - | - | 0.05 | - | 0 | Upgrade |
Total Current Assets | 1.82 | 0.16 | 0.28 | 0.11 | 0.01 | Upgrade |
Property, Plant & Equipment | 1.36 | 1.57 | 1.76 | - | - | Upgrade |
Long-Term Investments | - | - | - | 2.25 | 1.28 | Upgrade |
Goodwill | 1.27 | 1.68 | 1.27 | - | - | Upgrade |
Other Intangible Assets | 0.18 | 0.2 | 3.2 | - | - | Upgrade |
Total Assets | 4.63 | 3.6 | 6.51 | 2.36 | 1.29 | Upgrade |
Accounts Payable | 0.05 | 0.06 | 0.1 | 0.07 | 0.02 | Upgrade |
Accrued Expenses | 1.13 | 0.94 | 0.68 | 0.42 | 0.18 | Upgrade |
Short-Term Debt | 0.47 | 1.49 | 0.76 | 1 | 0.27 | Upgrade |
Current Portion of Long-Term Debt | 0.74 | 0.64 | 2.92 | - | - | Upgrade |
Current Income Taxes Payable | 0 | 0 | - | - | - | Upgrade |
Other Current Liabilities | 0.06 | 0.08 | 0.04 | 0 | 0 | Upgrade |
Total Current Liabilities | 2.45 | 3.2 | 4.51 | 1.49 | 0.46 | Upgrade |
Long-Term Debt | - | - | - | 0.59 | - | Upgrade |
Long-Term Deferred Tax Liabilities | 0.05 | 0.05 | 0.79 | - | - | Upgrade |
Total Liabilities | 2.5 | 3.25 | 5.3 | 2.08 | 0.46 | Upgrade |
Common Stock | 8.6 | 5.76 | 2.34 | 1.6 | 0.93 | Upgrade |
Additional Paid-In Capital | 6.77 | 5.33 | 3.47 | 0.88 | 0.69 | Upgrade |
Retained Earnings | -13.47 | -10.78 | -4.64 | -2.2 | -1.23 | Upgrade |
Comprehensive Income & Other | 0.22 | 0.05 | 0.03 | 0.02 | 0.45 | Upgrade |
Shareholders' Equity | 2.13 | 0.35 | 1.2 | 0.29 | 0.83 | Upgrade |
Total Liabilities & Equity | 4.63 | 3.6 | 6.51 | 2.36 | 1.29 | Upgrade |
Total Debt | 1.21 | 2.12 | 3.68 | 1.59 | 0.27 | Upgrade |
Net Cash (Debt) | 0.45 | -2.04 | -3.66 | -1.59 | -0.27 | Upgrade |
Net Cash Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade |
Filing Date Shares Outstanding | 4,299 | 2,878 | 1,171 | 799.02 | 464.14 | Upgrade |
Total Common Shares Outstanding | 4,299 | 2,878 | 1,171 | 798.52 | 464.14 | Upgrade |
Working Capital | -0.63 | -3.04 | -4.24 | -1.38 | -0.45 | Upgrade |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade |
Tangible Book Value | 0.69 | -1.52 | -3.27 | 0.29 | 0.83 | Upgrade |
Tangible Book Value Per Share | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | Upgrade |
Buildings | 0.74 | 0.74 | 0.74 | - | - | Upgrade |
Machinery | 0.86 | 0.86 | 0.86 | - | - | Upgrade |
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.